Member Info for Cloudy390

Well I think it’s not doing to bad, a bit of news on Accustem would make this fly I suspect. As after the confirmation from royal Marsden and eminent Italian institute a while ago, a bit of news now would not go amiss.

Well at the moment a 21cents approx as we are adr on otc we don’t qualify so hopefully they can trade this up as uk shares don’t have a look in at the moment.

Just read about it , google it , but possibly 6 months ,year . But I knew they could not just list on Nasdaq without proving something like turnover, profit, assets or trading history. Ya know Nasdaq ain’t Yo Yo,s

No Denny, reading up on listing on Nasdaq it requires one of a few regulations to be full filled, and the one most suited to Accustem IMO is a trading history, we have no income or asset value as such ,so trading history it is. Watch this space!!

Accustem as a new entity has to have trading history before Nasdaq will let it on,
Don’t people ever read up on wants going on, so wait and it will happen, at a lot high price than now, hopefully.

And wolves gathering for the kill ,they might find a Lion appears and trumps the lot of them!

https://api.londonstockexchange.com/api/gw/lse/download/TILS/trades

Is Watneys……..Lol
No just some good old fashioned news like::
COVID trial started
Uk grant approved and ok to trial.
MS trial update.
And dare I mention Accustem.
And expenditure for this year is smaller as not a lot of progress so far.
Will that do?????

What a lot of *******s . A demerger is agreed by the courts so just formality to follow.Business is easy, name of the game is making money .
Don’t think the board are losing sleep over this, if they are they don’t know what there doing,
It’s all happening now , UK agree trials and we are made ,if not???

https://www.proactiveinvestors.co.uk/companies/news/918186/tiziana-life-sciences-files-patent-for-combinational-treatment-for-coronavirus-918186.html

Me too!!

Looks like what Tils have said is coming true!!

it’s CRP by the way, sorry.

Long COVID now an issue, c-rap causes long COVID, Foralumab cuts the c-rap. GLA.

Pretty obvious really as in trials Teplizumab killed a few people I understand, so I wondered why it may pass FDA.

Lambda COVID variant on the loose. Tils , get foot on gas, to the floor, hurry.

The regular bid price of shares of the company's stock at the time of listing must be at least $4.00. However, a company may qualify under a closing price alternative of $3.00 or $2.00 if the company meets varying requirements

Bowllocks .
Min bid price for Nasdaq is $2 google it .

Float at $2 plus and stay there for a while , otherwise it will be kicked off if not above at least $2 or about 72p

Not if it floats high, or is sold .